Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.000
-0.090 (-8.26%)
At close: Nov 4, 2024, 4:00 PM
0.940
-0.060 (-6.00%)
Pre-market: Nov 5, 2024, 5:17 AM EST

Biofrontera Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-13.51-20.13-0.64-37.71-10.99-10.98
Depreciation & Amortization
1.161.061.170.540.560.67
Loss (Gain) From Sale of Assets
-----0.59
Loss (Gain) From Sale of Investments
3.017.42-1.75---
Stock-Based Compensation
0.871.051.850.13--
Provision & Write-off of Bad Debts
0.140.120.110.04-0.020.05
Other Operating Activities
-10.16-10.02-19.7311.790.9-4.06
Change in Accounts Receivable
-1.45-1.54-0.07-0.611.17-0.76
Change in Inventory
10.83-3.75-2.812.59-0.27-3.54
Change in Accounts Payable
-1.36.420.91-0.77-3.41.44
Change in Other Net Operating Assets
-8.51-5.524.76-2.71-0.32-21.08
Operating Cash Flow
-18.92-24.9-16.2-26.72-12.37-37.68
Capital Expenditures
--0.01-0.04-0.01--0.54
Cash Acquisitions
-----25.93
Investment in Securities
0.50.62-5.12---
Investing Cash Flow
0.450.62-5.16-0.01-25.4
Short-Term Debt Issued
-25.25----
Long-Term Debt Issued
----8.7913.5
Total Debt Issued
19.5525.25--8.7913.5
Short-Term Debt Repaid
--21.34----
Total Debt Repaid
-20.77-21.34----
Net Debt Issued (Repaid)
-1.223.9--8.7913.5
Issuance of Common Stock
19.614.5114.0243.19--
Other Financing Activities
----4.42.9
Financing Cash Flow
18.398.4114.0243.1913.1916.4
Net Cash Flow
-0.07-15.87-7.3316.470.834.12
Free Cash Flow
-18.92-24.9-16.24-26.73-12.37-38.22
Free Cash Flow Margin
-53.67%-73.08%-56.63%-110.90%-65.62%-145.96%
Free Cash Flow Per Share
-6.21-16.10-15.36-60.68--
Cash Interest Paid
1.870.15003.071.71
Cash Income Tax Paid
0.020.020.030.060.060.05
Levered Free Cash Flow
-17.96-24.792.36-9.66-9.11-
Unlevered Free Cash Flow
-16.45-24.412.59-9.43-7.3-
Change in Net Working Capital
6.6613.17-13.050.962.65-
Source: S&P Capital IQ. Standard template. Financial Sources.